Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

E-ISSN： 1875-5917|5|3|315-322

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.3, 2005-09, pp. : 315-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases

Current Pharmaceutical Design, Vol. 9, Iss. 3, 2003-01 ,pp. : 201-220

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Signaling and Metabolic Regulation of T Cells: New Potential Therapeutic Targets in Autoimmune Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 35, 2011-12 ,pp. : 3888-3897

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Glycolipid Ligands for Human iNKT Cells as Potential Therapeutic Agents for Immunotherapy

Current Medicinal Chemistry, Vol. 15, Iss. 23, 2008-10 ,pp. : 2337-2345

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA-21 with therapeutic potential in autoimmune diseases

By Xu Wang-Dong

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 659-665

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases

By Yan Jun-Wei Wang Yu-Jie Peng Wen-Jia Tao Jin-Hui Wan Ya-Nan Li Bao-Zhu Mei Bin Chen Bing Yao Hua Yang Guo-Jun Li Xiang-Pei Ye Dong-Qing Wang Jing

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 1, 2014-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite